Company Overview and News

Grand Gulf Energy neighbours Wildhorse Resource's oil and gas territory at Eagle Ford

Grand Gulf Energy Limited’s (ASX:GGE) securing of 881 net acres of prospective oil and gas territory in the high producing Eagle Ford region of Texas resulted in a surge in the company’s share price.
Upvote Downvote

Grand Gulf Energy updates on Boleslaw as eyes focus on Alabama

The Well spudded on 10 December 2016 and reached a total depth of 1550 metres on 10th January 2017, and intersected the designated objectives, however no commercial recoverable hydrocarbons were indicated.
Upvote Downvote

Update on Onshore Poland Well

2017-01-10 londonstockexchange
Prospex Oil and Gas Plc / Index: AIM / Epic: PXOG / Sector: Oil and Gas
Upvote Downvote

Grand Gulf Energy logs untapped oil at well in Alabama

Grand Gulf Energy (ASX:GGE) has confirmed the presence of untapped oil in the Smak Dixon 31-11 well in Pleasant Home Field located in the U.S. state of Alabama.
Upvote Downvote

Grand Gulf Energy advancing Boleslaw well in central Poland

The Boleslaw #1 Well was spudded on 11 December 2016 and is presently completing a casing run at 952 metres.
Upvote Downvote

Grand Gulf Energy well placed as drilling advances at Boleslaw well

Managing director of Grand Gulf Energy (ASX:GGE) Mark Freeman told Proactive the group was very well placed looking ahead. The firm, with a market cap of A$5.2mln has revenues from three producing fields, which generate over US$100,000 a month after costs, including royalties. It has funding, production revenues, reserves and upside opportunity, he added. It comes as the group's Boleslaw No.1 well was started earlier this week - and is expected to take just over three weeks to complete to a depth of about 1,500 metres.
Upvote Downvote

Grand Gulf Energy acquires interest in 87bcf gas prospect, drilling underway

Grand Gulf Energy (ASX:GGE) has acquired a 20.4% interest in the Boleslaw gas prospect in central Poland, which has a best estimate unrisked Prospective Resource of 87 billion cubic feet of gas.
Upvote Downvote

Kolo Licence Update

2016-12-13 londonstockexchange
Prospex Oil and Gas Plc / Index: AIM / Epic: PXOG / Sector: Oil and Gas
Upvote Downvote

GGE Market Update

Upvote Downvote


Related Articles

GNCA: Genocea Biosciences Analysis and Research Report

2018-04-25 - Asif

Overview Genocea Biosciences is a biopharmaceutical company that discovers and develops novel cancer vaccines. The company use its proprietary discovery platform, ATLAS, to recall a patient’s pre-existing CD4+ and CD8+ T cell immune responses to their tumor to identify antigens for inclusion in vaccines that are designed to act through T cell (or cellular) immune responses. The company believe that using ATLAS to identify antigens for inclusion in cancer vaccines could lead to more immunogenic and efficacious cancer vaccines. In September 2017, the company announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines. Currently, all of its research programs and product candidates in active development are at the preclinical stage. The company's most advanced program is its preclinical immuno-oncology program, GEN-009, a neoantigen cancer vaccine. The GEN-009 program uses ATLAS to identify patient neoantigens, or newly formed anti...

AMZN:, Inc Analysis and Research Report

2018-04-25 - Asif

Overview opened its virtual doors on the World Wide Web in July 1995. The company seek to be Earth’s most customer-centric company. Amazon is guided by four principles: customer obsession rather than competitor focus, passion for invention, commitment to operational excellence, and long-term thinking. In each of its segments, the company serve its primary customer sets, consisting of consumers, sellers, developers, enterprises, and content creators. In addition, the company provide services, such as advertising services and co-branded credit card agreements. Amazon has organized its operations into three segments: North America, International, and Amazon Web Services (“AWS”). These segments reflect the way the Company evaluates its business performance and manages its operations. Additional information on its operating segments and its net sales is contained in Item 8 of Part II, “Financial Statements and Supplementary Data—Note 11—Segment Information.” The compan...

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...